Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children

Pediatric Neurology

Volumn 43, Issue 5, 2010, Pages 320-324

  Misra, Abhijit ^a   Aggarwal, Anju ^a   Singh, Om ^b   Sharma, Sangeeta ^c  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CARBAMAZEPINE; PARATHYROID HORMONE; PHOSPHORUS; VALPROIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BENIGN CHILDHOOD EPILEPSY; BLOOD PH; BONE MINERALIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; PARATHYROID HORMONE; PROSPECTIVE STUDIES; STATISTICS AS TOPIC; VITAMIN D;

EID: 77957737092     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.05.013     Document Type: Article

References (23)

1. M.V. Johnston Seizures in childhood R.M. Kleigman, R.E. Berhman, G.B. Jenson, B.F. Stanton, Nelson textbook of pediatrics 18th ed 2004 Saunders New Delhi 2457 2478
2. H. Tekgul, G. Serdaroglu, A. Huseyinov, and S. Gökben Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy J Child Neurol 21 2006 411 414
3. P. Nicolaidou, H. Georgouli, and H. Kotsalis Effects of anticonvulsants therapy on vitamin D status in children: Prospective monitoring study J Child Neurol 21 2006 205 209
4. J. Rajantie, C. Lamberg-Allardt, and M. Wilska Does carbamazepine treatment lead to a need of extra vitamin D in some mentally retarded children? Acta Paediatr Scand 73 1984 325 328
5. S.H. Kim, J.W. Lee, K.G. Choi, H.W. Chung, and H.W. Lee A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy Epilepsy Behav 10 2007 291 295
6. A. Babayigit, E. Dirik, E. Bober, and H. Cakmakci Adverse effects of antiepileptic drugs on bone mineral density Pediatr Neurol 35 2006 177 181
7. A. Verrotti, R. Greco, G. Latini, G. Morgese, and F. Chiarelli Increased bone turnover in pre-pubertal, pubertal and post-pubertal patients receiving carbamazepine Epilepsia 43 2002 1488 1492
8. M. Ala-Houhala, R. Korpela, M. Koivikko, T. Koskinen, M. Koskinen, and T. Koivula Long term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children Neuropediatrics 17 1986 212 216
9. L. Tjellessen, A. Golfredsen, and C. Christiansen Effect of vitamin D2 and D3 on bone mineral content in carbamazepine treated epileptic patients Acta Neurol Scand 68 1983 424 428
10. S. Mintzer, P. Boppana, J. Toguri, and A. DeSantis Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbamazepine Epilepsia 47 2006 510 515
11. H. Valsamis, S.K. Arora, B. Labban, and S.I. McFarlane Antiepileptic drugs and bone metabolism Nutr Metab (Lond) 3 2006 36
12. R. Kruse Osteopathies in antiepileptic long-term therapy (preliminary report) Monatsschr Kinderheilkd 116 1968 378
13. A.M. Pack, and M.J. Morrell Adverse effect of antiepileptic drug on bone structure: Epidemiology mechanisms and therapeutic indications CNS Drugs 15 2001 633 642
14. H. Gough, T. Goggin, A. Bissessar, M. Baker, M. Crowley, and N. Callaghan A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy Q J Med 59 1986 569 577
15. V. Hoikka, E.M. Alhava, and P. Karjalainen Carbamazepine and bone mineral metabolism Acta Neurol Scand 70 1984 77 80
16. L. Tjellesen, and C. Christiansen Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants Acta Neurol Scand 66 1982 335 341 (Pubitemid 12061608)
17. N. Collins, J. Maher, M. Cole, M. Baker, and N. Callaghan A prospective study to evaluate the dose of vitamin D required to correct low 25- hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia Q J Med 286 1991 113 122
18. B.P. Schmitt, D.J. Nordlund, and L.A. Rodgers Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy J Fam Pract 18 1984 873 877
19. E. Erbayat Altay, A. Serdarolu, L. Tümer, K. Gücüyener, and A. Hasanolu Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid J Pediatr Endocrinol Metab 13 2000 933 939
20. M.A. Mikati, L. Dib, B. Yamout, R. Sawaya, A.C. Rahi, and Gel-H Fuleihan Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone Neurology 67 2006 2005 2014
21. J. Silver, T.J. Davies, E. Kupersmitt, M. Orme, A. Petrie, and F. Vajda Prevalence and treatment of vitamin D deficiency in children on anticonvulsant drugs Arch Dis Child 49 1974 344 350
22. K.K. Borowicz, M. Morawska, K. Furmanek-Karwowska, J.J. Luszczki, and S.J. Czuczwar Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock Eur J Pharmacol 573 2007 111 115 (Pubitemid 47464219)
23. K.D. Cashman Vitamin D in childhood and adolescence Postgraduate Med J 93 2007 230 235